Pfizer

CMOs See Big Benefits From AI-Driven Customer Insights
CMOs See Big Benefits From AI-Driven Customer Insights
January 12, 2024  |  artificial intelligence

CES 2024 was more than an occasion to introduce new gadgets, robots and artificial intelligence (AI)-driven product development. Turns out that marketers want to play...

READ MORE >
Lipstick Goes AI at CES
Lipstick Goes AI at CES
January 10, 2024  |  artificial intelligence

CES 2024 is shaping up to be a watershed event for artificial intelligence (AI) and the connected economy. After the pre-show hype focused on robotics...

READ MORE >
Elon Musk Reports ‘Massive Drop in Revenue’ as Companies Pause Twitter Ads
Elon Musk Reports ‘Massive Drop in Revenue’ as Companies Pause Twitter Ads
November 04, 2022  |  Acquisitions

With activist groups pressuring advertisers to leave Twitter after its acquisition by Elon Musk, the social media platform has seen “a massive drop in revenue,”...

READ MORE >
Amazon, Pepsi, Others Agree to Hire 20K Refugees
Amazon, Pepsi, Others Agree to Hire 20K Refugees
September 19, 2022  |  Personnel

Amazon, Pepsi and Pfizer are among a host of companies that have agreed to hire 22,725 refugees to fill jobs in the U.S. That’s according to...

READ MORE >
GSK, Pfizer Consumer Health Spinoff Set to Launch in July
GSK, Pfizer Consumer Health Spinoff Set to Launch in July
April 27, 2022  |  Healthcare

GlaxoSmithKline (GSK) is getting ready to launch its consumer health spinoff with Pfizer this summer, the company said in its first-quarter earnings report Wednesday (April...

READ MORE >
GlaxoSmithKline, Unilever Spar Over Future of GSK’s Consumer Health Business
GlaxoSmithKline, Unilever Spar Over Future of GSK’s Consumer Health Business
January 16, 2022  |  Healthcare

GlaxoSmithKline and Pfizer will hold out for a better bid of at least £60 billion for their joint consumer healthcare venture, in opposition to an...

READ MORE >
Pfizer, Moderna Could Make Billions From COVID Boosters
Pfizer, Moderna Could Make Billions From COVID Boosters
August 13, 2021  |  Coronavirus

Pfizer and Moderna could make billions of dollars from COVID-19 booster shots, earnings comparable to the $6 billion generated each year in flu vaccine sales....

READ MORE >
Euphoria In Israel As Pfizer Vaccine Ends Lockdown
Euphoria In Israel As Pfizer Vaccine Ends Lockdown
March 14, 2021  |  Coronavirus

In Israel, with 4 million of its near 7 million adults vaccinated, the country is reveling in its reopening, Financial Times (FT) reports. The country...

READ MORE >
First Pfizer-BioNTech COVID-19 Vaccines Administered In US
First Pfizer-BioNTech COVID-19 Vaccines Administered In US
December 14, 2020  |  Coronavirus

The first doses of the Pfizer-BioNTech COVID-19 vaccine, outside of clinical trials, started being administered to healthcare workers and nursing home staffers on Monday (Dec.14)....

READ MORE >